Contact – +91 9607683178
 Email – sales@supplydemandmarketresearch.com

Home >> Latest Reports

 LATEST REPORTS


 PRESS RELEASES


Food Safety Testing Market, By Contaminants (Pathogens, Toxins, GMO's, Pesticides), Technologies (Chromatography, Culture Assay, Bio-Chips), End User (Meat & Poultry, Diary, Processed Food, Fruits & Vegetables) - Global Market Trends & Forecasts Upto 2023

Food Safety Testing Market The total food safety testing market is valued at USD 12.9 billion as on 2017 and is anticipated to reach USD 20 billion by the end of 2023, growing at a CAGR of 7.5%. The main growth driving factors include stringent international standards and regulation, improvements in food safety, performance and quality, continuous food inspection, and advances in food testing technologies. Factors like increasing incidences of foodborne illness, globalization of food supply chain management, easy accessibility of advanced Rapid Technologies and increasing awareness about chemical contamination in food industrial sector are the prime drivers that fuels the growth of the Global food safety testing market. In addition, the strict government rules and norms coupled with the increasing demand of ready to eat food products are also responsible in driving the need for testing of food products that are available in the market. However, the expensive cost of food safety testing services along with the lack of food safety infrastructure in developing regions are expected to hamper the growth of this market. Moreover, the long and time consuming testing processes, and lack of standardization in sample collection serves to be the major challenges of safety testing market. The growing consumer awareness about food safety and its methods coupled with the increasing count of capital investments are anticipated to create great opportunities for food safety testing market in the developing countries. The food safety testing market is segmented on the basis of contaminants, testing technologies, end users and region. On the basis of contaminants this market is further fragmented into the pathogens, toxins, genetically modified organisms (GMO), pesticides and others. The pathogen category for the elaborated into E. Coli, Campylobacter, Listeria, Salmonella and Other. Among which, the pathogen segment is expected to have the largest Market share in 2017; due to its major role in making the food toxic and degrading the food quality. Moreover, the increasing prevalence of foodborne illness and other conditions are further expected to propel the growth of this market. On the basis of testing technologies, the food safety testing market is classified into chromatography, culture media, rapid assays, emerging technologies, biosensors or biochips and others. Chromatography is expected to dominate the market during the forecast period, accounting to the increasing research and development activities, technical advancements in food safety processes and optimization of food testing methods. However, the applications of biosensors or biochips is further expected to create awareness about food safety measures and thus it is responsible for fueling the growth of food safety testing market. On the basis of end users the food safety testing market is fragmented into meat & poultry, dairy products, processed food, seafood, beverages, fruits & vegetables, and others. Processed foods led this market during the base years, but the increasing consumption of meat and poultry products is expect to hold the largest market share during the forecast. As meat and poultry products are more susceptible to contamination. However, the adoption of Hazard Analysis Critical Control Points or HACCP in slaughterhouse and processing plants prevents the contamination of food products and assures the delivery of quality food products to the consumers. On the basis of region, the food safety testing market is segmented into North America, Europe, Asia and Row. Overall, North America dominates this market, due to the presence of major players in this region, elevating count of population, adoption and implementation of strict norms to assure quality food products are some of the prime factors fuelling the growth of this market. In addition, the supportive government against food contamination coupled with the increasing count of working women is also elevating the need for packed and convenience food in the market, which is further increasing the demand of food safety testing. The leading major players in the market are Eurofins, SGS SA, Intertek Group PLC, Bureau Veritas S.A., ALS Limited, Microbac Laboratories, Inc, Bureau Veritas SA, Neogen Corporation, SCS Global Services, Microbac Laboratories, Laboratory Corporation of America Holdings, Mérieux Nutrisciences, Asurequality Ltd., Romer, Labs Division Holding GmbH, and Genetic ID NA, Inc. ...

 3/27/2018 |  Food & Beverage


Bio-Stimulants Market, Type (Cereals, Oilseeds, Turfs & Ornamentals, Fruits & Vegetables), Ingredient (Humic Acid, Fulvic Acid, Vitamins, Amino Acids), Application (Foliar Treatment, Seed Treatment, Soil Treatment) - Global Market Trends & Forecasts Upto 2023

Bio-Stimulants Market The total food safety testing market is anticipated to reach USD 3.6 billion by the end of 2023, growing at a CAGR of 10.8% from 2018-2023. The bio-stimulant market is majorly driven by the increasing adoption of eco-friendly and organic food products in the market. Some of the other factors contributing towards the growth are growing focus on enhancement of yield and productivity per hectare and implementation of precise farming. Additionally, the strong product portfolio and enhancement of market portfolio in developing region create great opportunities for bio-stimulants. However, the availability of substitutes, expensive research and development activities, lack of awareness among farmers and time consuming process hampers the growth of bio-stimulants market. Additionally, the adoption of plant phenotyping and focus on farm profitability are the major trending issues that are responsible for increasing the adoption of bio-stimulants by the farmers. The bio-stimulants market is segmented on the basis of crop type, form, active ingredients, applications and geography. On the basis of crop type, the market is further fragmented into cereals, oil seeds, turfs & ornamentals, fruits & vegetables and others. Among which, cereals segment has the largest market share, which is due to the increased production of food grains in order to feed the elevating population, adoption of sustainable farming practices due to the availability of limited land and water and the positive effect of bio-stimulants against abiotic stress. On the basis of form, the bio-stimulant market is categorized into dry and liquid bio-stimulant. The dry formulation of bio-stimulant is recorded to have largest market share in the base year. Factors like easy handling and transportation, improvement in photosynthesis coupled with lateral but development process, delaying of aging process of plant tissues and promotion of cell division and plant respiration activity results in increased demand of dry form of bio- stimulant in the market. The active ingredient category of bio-stimulants market is fragmented into humic acid, fulvic acid, trace minerals, seaweed extracts, microbial soil amendments, vitamins, amino acids, chitin & chitosan, protein hydrolysates, and others. The seaweed extracts segment holds the largest market share and is expected to grow with the same pace during the forecast years. It may be due to the benefits of extract based ingredients in terms of aeration and advanced soil structures, elevation of seed germination processes, and growing of biotic and abiotic tension resistant yield. On the basis of application, the bio-stimulant market is categorized into foliar treatment, seed treatment, soil treatment, potassic, and others. The foliar segment holds the largest market share, owing to the efficiency of foliar sprays for instant results, enhanced productivity factor, high rate of absorption and enhanced farming technologies. Geographically, the bio-stimulant market is divided into North America, Europe, Asia and ROW. Among all, Europe, followed by Asia, is expected to dominate this market. Factors like growing awareness about susceptible farming, increasing demand of important fruit and field crops, strict rules on environmental safety, and increasing capital investments in research and development activities are responsible and boosting the growth of bio-stimulants market. The key players operating in this industry are Arysta Life science Limited, Biolchim S.P.A., Biostadt India Limited, Isagro S.P.A., Italpollina S.P.A., Lida Plant Research S.L., Monsanto Company, Novozymes A/S, Syngenta Ag, and Valagro S.P.A. ...

 3/27/2018 |  Food & Beverage


Healthcare BPO Market by Services (Revenue cycle management, Patient enrollment, Medical coding, billing and collection services), by facility (Large health systems, Stand-alone hospitals, Ambulatory surgical centers) - Global Industry Trends & Forecasts Upto 2023

The healthcare BPO market is estimated to reach USD 330 billion by 2023 growing at a CAGR of 11.0 from 2018-2023. The healthcare BPO market is primarily driven by elevating cost-saving factor, growing perception for recovery audits coupled with increasing research and development activities. However, the service reliability issue along with the complications and concerns of data privacy may hamper the growth of this market. In addition, implementation of IT in Healthcare sector serve to be the growing opportunity for healthcare BPO market. The adoption of BPO services is also responsible for propelling the growth of the market. The healthcare BPO market can be segmented into payer services, provider services, and pharmaceutical services. The payer services can be further segmented into human resource management, claims management, Customer Relationship Management (CRM), operational/administrative management, product development, care management and provider management. The induced pressure to reduce elevating Healthcare expenditures, increasing demand of niche services, increasing demand of ICD-10 over ICD-9, adoption of automation and integrated sourcing strategies and demand and recovery audits are some of the prime factors responsible for propelling the growth of this market. The provider services of healthcare BPO market provider is further segmented into patient enrollment and strategic planning, medical billing, medical transcription, device monitoring and revenue cycle management. On the basis of provider service, revenue cycle management is expected to grow at a steady pace during the forecast period. The growing revenue cycle management market further counts to the decreasing reimbursements in the healthcare industry, resulting in the reduction of overall Healthcare expenditure coupled with supportive government policies fuels the growth of this segment in Healthcare BPO market. The Pharmaceutical segment of this market is further classified into manufacturing outsourcing, clinical data management, and pharmacovigilance services. Factors like increasing research and development activities, strict norms, adoption of IT in the healthcare sector, and upsurge demand in RCM plays a significant role in fueling the growth of the market. However, the lack of proper and accurate information and Communication Technology infrastructure coupled with interoperability issues and lack of domain expertise may restrict the growth of the market. Geographically, the healthcare BPO market segmented into North America, Europe, Asia, and ROW. On the basis of geography, North America dominates this market, accounting to the growing economic growth rate and increasing Healthcare expenditure throughout this region. This further resulted in increasing investments in Technologies responsible for simplifying the healthcare systems and services that further drive the growth of this market. Moreover, the adoption of BPO services in the healthcare industry, increase in medical transcription outsourcing services and adoption of cloud-based BPOs healthcare sector are for the responsible in creating great opportunities for this market. However, the increasing doubts over the quality of services, high attrition rate, and privacy concerns and data security issues may restrict the growth of the market. The key players operating in this industry are Accenture, Tata Consultancy Services, Genpact, Boehringer Ingelheim GmbH, Cognizant, Charles River Laboratories International Inc., Covance Inc., Infosys Limited, Lonza Group Ltd. and Quintiles Inc. ...

 3/27/2018 |  Healthcare


eClinical solutions Market By Product (Electronic Data Capture and Clinical Data Management Systems Clinical Trial Management Systems), By (Phase I, Phase II, Phase III, Phase IV)-Global Trends & Forecasts Upto 2023

The e-clinical solutions market is estimated to account for USD X.X billion in 2017, and is projected to grow at a CAGR of X.X% to reach USD X.X billion by 2023. The market is majorly driven by the increasing count of clinical trials, rising number of government funding for such trials, growing need for improved data standardization, regulatory requirements associated with clinical research studies and increasing research and development of activities by pharmaceutical and biotechnology based companies. In addition, the adoption of global software solutions in clinical research studies, access data mounting from Healthcare industry and the presence of wide and strong range of products in the pipeline are another factors that boost the growth of this market. However, the lack of awareness about the benefits of a clinical solution coupled with the infrastructure of these solutions are the prime factors hindering the growth of the market. Additionally, the lack of skilled professionals and high implementation cost associated with the e-clinical solution software also restricts the demand for e-clinical solutions. Moreover, the factors like growing clinical Research activities in developing region coupled with the outsourcing of clinical trial processes are expected to create more opportunities for this market. But, the software reliability issues and patient privacy concerns still serves to be the major challenges of e-clinical solutions market. The e-clinical solutions market is segmented on the basis of product, type, delivery model, phase of clinical trials, end-users and region. On the basis of products, the market is fragmented into Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, Biostatistics and statistical programming solutions, Data conversion and standardization solutions, Electronic patient reported outcome solutions, e-clinical integration solutions, and Other e-clinical Solutions. On the basis of types, the e-clinical solutions market is categorized into standalone and integrated systems. Whereas on the basis of delivery models, this market is fragmented into on-premises e-clinical solutions and on-demand or cloud-based e-clinical solutions. The on-demand e-clinical solution segment is growing at a faster rate, accounting to the increasing applications of internet of things, real time study management, adoption of standard and ad hoc reporting, etc. On the basis of phase of clinical trials, this market is categorized into Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, and Phase IV Clinical Trials. Whereas, the end-user category comprises of pharmaceutical and bio-pharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, and hospitals. Among all, the pharmaceutical and bio-pharmaceutical companies is expected to dominate this market, owing to the increasing research and development activities for new product development, adoption of a centralized place to carry out all the trials related information and the improvement in clinical data management by the involvement of staff and data administrators. Geographically, the market is segmented into North America, Europe, Asia and ROW. North America dominate this market, accounting to the elevating count of clinical trials, increasing research and development activities for the development of new product, supportive government policies and changing lifestyles. However, the Asian region is also reported to have a steady growth rate during the forecast years, owing to the increasing research and development activities in this region. The key players operating in this industry are BioClinica, CRF Health, Datatrak International, Inc., Medidata Solution, Inc., Merge Health Incorporated, OmniComm Systems Inc., Oracle Corporation, and Parexel International Corporation. ...

 3/27/2018 |  Healthcare


Healthcare Analytics Market, Type (Prescriptive, Predictive, Diagnostic), Component (Hardware, Software, Services), Application (Financial, Clinical, Population Health Management), End- User (Payers, Providers, ACOS) - Global Market Trends & Forecasts upto 2023

The healthcare analytics market is estimated projected to grow at a CAGR of 28.0 % to reach USD billion by 2023. High adoption rates of electronic health record systems coupled with the application of big data in healthcare and increasing investment expenditures in healthcare industry is also boosting the growth of healthcare analytics market. However, the lack of skilled IT professionals coupled with the penetrating data integrity issues are the major restraints of healthcare analytics market. In addition, the implementation and applications of electronic health records, focus on value-based medicines and growing adoption of cloud-based analytics serve to be the prime opportunities for this market. The healthcare analytics market can be segmented on the basis of type, component, delivery mode, application, and end-user. On the basis of type, the healthcare analytics market can be segmented into descriptive analytics, diagnostic analytics, predictive analytics, and prescriptive analytics. The descriptive analytics segment, on the basis of types of healthcare analytics market, is reported to have the largest market share, owing to the increasing supportive and favorable healthcare policies that are launched by the government, progressive outcomes of clinical processes and the positive impact of social media on the healthcare industry. On the basis of components, the healthcare analytics market can further be segmented into services, software, and hardware. The services segment is further categorized as support services and business analytics services; whereas the software segment is further divided into standalone and integrated. Based on components of Healthcare analytics market, the services segment holds the largest market share accounting to the elevating need for business analytics services coupled with the advancements in technical healthcare analytics software. In addition, the emerging requirement of personalized and evidence-based medicine is also responsible for increasing the demand for service-based healthcare analytics software in the market. On the basis of delivery mode, this market is further categorized as on-premise healthcare analytics and on-demand /cloud healthcare analytics. On the basis of the delivery model of healthcare analytics market, the on-demand healthcare analytics segment is expected to grow at a steady pace; accounting to the higher flexibility, upsurge need for self-driven analytics, and pay-as-you-go cost factor. Moreover, the lack of increasing capital investments in the healthcare sector is also responsible for fuelling the growth of this market. On the basis of application, the market is fragmented into financial analytics, clinical analytics, operational and administrative analytics, and population health management/analytics. On the basis of applications of Healthcare Analytics market, operational and Administrative Services dominated this market in 2015, accounting to the elevated count of application including strategic Analytics, supply chain management and workforce. However, the financial applications are also expected to have an anticipated growth during the forecast, owing to the increasing adoption of Healthcare analytics in both governments as well as private healthcare departments. Lastly, on the basis of end-users, the healthcare analytics market is segmented into payers, providers, ACOS, HIES, MCOS, and TPAS, and third-party business analytics service providers. On the basis of end users, the payers segments are expected to dominate this market during the forecast years, accounting to the involvement and application of these services quality improvement, population health management, and personalized care. However, the increasing efficiency in Healthcare sector coupled with the reduction in the unnecessary and unwanted expenditure is also responsible for dominating this segment. Geographically, the market is divided into North America, Europe, Asia, and ROW. Geographically, North America dominates the Healthcare analytics market followed by Europe and Asia; accounting to the technological advancements in Healthcare services, implementation of regulatory clauses, and increasing government incentives that are focusing on the manufacturing and applications of personalized and customized medicines. However, the expensive nature of analytics software and services, increasing data integrity issues, the complexity of software and intensified competition may hamper the growth of Healthcare analytics market. The key players operating in this industry are Cognizant, Health Catalyst, IBM, Mede Analytics, Inc., MedAssets, Inc., McKesson Corporation, Optum, Oracle, Inc., SAS Inc., Truven Health Analytics, and Verisk Health. ...

 3/27/2018 |  Healthcare


Infection Control Market By Type (Disinfectants, Sterlization, Medical Non-Wovens, Disinfectors), End-User (Hospitals, Medical Devices, Pharmaceuticals, Life Science Industry, Clinical Laboratories, Food Industry - Global Market Trends & Forecasts Upto 2023

The Infection Control market is estimated 25 billion by 2025 growing at a CAGR of 6.0 % from 2018-2025. Factors like increasing prevalence of hospital acquired infections, elevating count of surgical procedures, strict safety norms and regulations, and technical advancements in sterilization processes search to be the driving factors of this market. However, sterilization of advanced medical instruments and increasing concern related to safety of reprocessed instruments hamper the growth of this market. Additionally, high adoption rate of E-beam sterilization and merger of pharmaceutical and medical device manufacturer are also boosting the growth of the infection control market, globally. Moreover, the non-compliance issues by the end users with respect to the sterilization standards is the prime challenging factor for this market. The infection control market is segmented on the basis of products & services, end user and geography. On the basis of products & services, the market is further fragmented into sterilization products and services, disinfectants, medical non-woven and disinfector. Among all, the disinfection segment holds the largest market share, owing to the growing application of infection control systems in hospitals, the growing need for reduction of cross contamination in food and Pharmaceutical sectors and the high adaptability rate of skin and hand disinfectants. Additionally, the infection control market is also segmented on the basis of end-user, as hospitals, medical device companies, pharmaceutical companies, life science industry, clinical laboratories, food industry and others. Hospital segment dominates this market, accounting to the increasing prevalence of hospital acquired infections, elevating health related expenditures due to the increasing count of elderly population and chronic diseases. Moreover, the threat of infectious diseases like AIDS, Ebola and antivirus in the last 3 decades is also responsible in fueling the growth of the market. On the basis of geography, North America dominates this market, followed by Europe, Asia and ROW. The increasing demand for infection control products, growing awareness about hygiene and infection free environment coupled with increasing count of surgical processes also plays an important role in propelling the growth of infection control market in North America. In addition, the supportive government policies, changing lifestyles and growing geriatric population further increases the demand for infection control systems. Asian region is also expected to have a study growth during the forecast years, accounting to the growing economies of developing countries like India and China, increasing prevalence of nosocomial infections coupled with the improvement and expansion of healthcare infrastructure of this region. However, the growing outsourcing trend by the established key players of developed regions to the company's present in Asian regions is also responsible in boosting the growth of infection control market. The key players operating in this industry are 3M Company, Ahlstrom Corporation, Belimed AG, Cisa S.p.A, Getinge Group, Honeywell International, Inc., Johnson & Johnson Limited, Kimberly-Clark Corporation, Matachana Group, Nordion Inc., Sakura Global Holding Company Ltd., Sterigenics International, Inc., STERIS Corporation, Synergy Health plc, and TSO3 Inc. ...

 3/27/2018 |  Healthcare


Software Defined Everything Market By Type (Software-Defined Networking, Software Defined Data Centre, Software Defined Computing, Software Defined Storage), Services (Managed, Consulting, Integration and Deployment), Vertical (IT, Telecom, Healthcare, BFSI, Manufacturing, Logistics) - Global Trends & Forecasts Upto 2025

Software Defined Everything (SDE) specifies the shift of technology in software defined way for accessing the storage, networks and data centers. The main function of SDE is to reduce the silos in the market. Software defined everything is segmented on the basis of type and application. The type segment is further bifurcated into SDN, SDS and SDDC. SDN offers a great amount of flexibility and more control over the programs and how the data packets and traffic travels across your network. Cloud Computing plays vital role in the development and growth of SDE and SDN (Software defined networking). Many IT companies are adopting cloud computing in the network infrastructure for the better and efficient management. SDN helps in allowing the cloud service providers to host multiple number of virtual networks without any need of common separation isolation methods. The SDE Market is expected to grow at a CAGR of 28% during the forecast period 2017–2023. The SDE market is driven by IoT and cloud computing adoption across industry verticals such as BFSI, aerospace & defense, retail, food & beverages, healthcare and automotive. The major players included in this report are Dell, HPE, VMware, Extreme Networks, Nexenta Systems, Riverbed Technology, Silver Peak, Metaswitch Networks, Pivot3, Infoblox and others. This report offers major trends, industry trends which is going to play a major role in SDE market during the forecasted year. Moreover, this report can also tailored as per the requirement by the users, and also available with deeper segmentation by regions, countries, and vendor profiling. ...

 3/27/2018 |  ICT


Expanded Polystyrene (EPS) Market Type (Black, White, Grey), By Application (Building & Contruction, Packaging, Electrical & Electronics, Automotive, Cold Storage) – Global Market Trends & Forecasts upto 2023 

The total expanded polystyrene (EPS) market is expected to grow at a CAGR of 5.3% from 2017-2023 and reach $ 19.9 billion by 2023. Increasing population and urbanization in developing countries such as India, Thailand, Brazil, etc. have resulted in the growth of manufacturing sectors such as automotive, packaging, and building & construction. This growth in different industries coupled with the huge demand for packaging solutions in the food and beverage & medical and pharmaceutical sector to enhance product safety and freshness of packaged food and medicines during transportation largely drive the EPS market growth. In terms of types of EPS, white EPS accounted for the largest market share in 2017, followed by black and grey EPS. White EPS exhibits superior mechanical durability and water resistant properties, which make it suitable for various end-use industries. EPS finds its heavy utility in the building and construction sector. In 2017, the packaging and building & construction sectors emerged as the leading end use industries capturing market share. Major packaging applications include retail, food, and consumer goods. The rising demand for EPS in cold chain packaging solutions is expected to drive the market for EPS in the packaging sector. Its applications in the building and construction sector include insulated panel systems for walls, roofs, and floors as well as facades for both domestic and commercial buildings. Rising growth in the building and construction industry will eventually result in the growth of the EPS market. Automotive is another significant end use industry for EPS. Asia-Pacific was the most favoured market for EPS in 2017 that bagged the largest market share. The region is expected to grow at the fastest rate of 6.3% from 2017-2023 that will remain the leading market in 2023 as well. China subjugated the EPS market in Asia-Pacific due to the growing electrical and electronic and packaging application in the country. A shift of manufacturing companies to India, China, Indonesia, etc., has been observed because of the availability of low cost labour and raw materials. The demand for EPS in North America and Europe has been anticipated to grow at a moderate rate. EPS is banned in food packaging applications in several states of the U.S. as EPS waste causes tremendous trouble when it leaks into marine environments and contaminates water. However, EPS recycling techniques are now trending in Europe. Greenmax, DUE Recycling Systems, etc., are the companies that provide solutions to recycle EPS. The market is highly fragmented due to the presence of a large number of EPS manufacturers. Companies are working closely with consumers to address their need regarding EPS and with their latest R&D companies that are designing EPS products with exceptional properties. In 2014, BASF started to use an innovative flame retardant “PolyFr”. All of BASF’s Styropor, Neopor, and Styrodur polystyrene products for the European market have better flame retardant properties than HBCD (hexabromocyclododecane), which was used in the past. Some of the major players that operate in this market are BASF, SABIC, INEOS, Total SA, Nova Chemicals Corporation, Synthos S.A., Alpek S.A.B. De Cv, PJSC Sibur Holding, ACH Foam Technologies Inc., Versalis S.P.A, Nova Chemicals Corporation, Synbra Holding BV and Flint Hills Resources, LLC, & others. ...

 3/6/2018 |  Chemicals & Materials


Service Robotics Market, By Operating Environment (Aerial, Ground-based, Marine), Application (Professional Application, Personal Application) - Global Market Trends & Industry Forecasts Upto 2023

The market for social robots has reached $ 7.9 billion in 2017, an increase of 7.0% over the previous year. Professional service robots accounted for two-third of the overall market and are expected to account for a major share of the service robotics market through 2023. The increase in market is expected to be driven by the increasing demand for logistics robots in manufacturing and non-manufacturing sectors, defense applications robots, and inspection and maintenance robots. Robots have now moved beyond the realm of traditional jobs doing repetitive functions, such as assembling of parts and welding, in the manufacturing and automotive industries. With the advancement in technologies, robots are becoming smarter and intelligent fostering the dissemination of new technologies and new innovations advancing the ability of robotics to assist and support humans perform several tasks. Service robots are slowly becoming ubiquitous, delivering newer efficiencies across several applications from assisting in personal tasks to professional services. With the growing integration of robotics with digital forces, such as cloud, artificial intelligence, and analytics, service robotics are bridging the gap between theory and practice in all areas of robotics and intelligent systems. [<<img 10.png>>] The value chain of the service robotics ecosystem comprises several companies and research institutes to provide several activities from research and design to manufacturing and assembly of components to services. Service robotics are witnessing signs of robotic revolution with several startups entering the space backed by several venture capitalists as well large conglomerates incubating the newer technologies. Companies in the robotic value chain range from diverse applications. The focus of service robotics is shifting to the advanced robots with high level of artificial intelligence in terms of their interaction with the environment and the ability to continuously improve their decision making based on external feedback. Service robots have potential market in several new applications across several sectors, including logistics, education, defense and security, healthcare, agriculture and forestry, entertainment, space, domestic tasks, personal and elderly assistance, home security. Several companies are focusing on developing world class robots that are human friendly and add value to the people and businesses that deploy them. The market for social robotics is expected to be driven by the Shift from trend from the strictly structured environments into the unstructured environments and also shorter payback period and higher return on investment. Growing demand for drones from military and non-military applications also expected to boost the demand for drones. However, increase in aging population across the world would encourage the demand for rehabilitation of robots, growth potential across developing nations, persistent requirement of technologically advanced service robots, especially from defense and security verticals are presenting opportunities for service robotics. In addition, the advancements in self driving cars and artificial enabled social robots will have a potential market across the globe. Robots are expected to play a key role throughout the retail value chain including both front-end and back-end operations with the integration of big data and analytics and cloud computing, Pervasive Computing, and artificial intelligence. Several social robots are expected to hit the market in 2018-2019 with the advanced technologies and capabilities to help humans of different age groups from kids to elderly assistance. In January 2018, Paaila Technology (Nepal) launched waiter robot, a smart, reliable and autonomous robot to take valued customers' food order from kitchen to table. The company also plans to launch Room Service Robot in February 2018. In January 2018, Aflac Incorporated (US) unveiled a smart robotic companion, “My Special Aflac Duck” for children who have cancers. In January at CES 2018, Aeolus Robotics launched the Aeolus Robot, a multifunctional in-home robot powered by artificial intelligence (AI) and machine learning. FoldiMate, Inc. (US) is expected to ship the improved model of robotic laundry folding machine for home use by late 2019. North America has been dominating the market for service robotics and is expected to continue to account for the major market through 2023, followed by Europe. Technological advancements and new product developments have accounted for the major driving factor for North American market to hold the largest market share among all regions. Moreover, the presence of major players such as Amazon.Com, Inc. (U.S.), Bluefin Robotics (U.S.), iRobot Corporation (US), Google, Inc. (U.S.), Adept Technology, Inc. (U.S.), GeckoSystems Intl. Corp. (U.S.) and Northrop Grumman Corporation (U.S.) in the North American region also contribute significantly toward the growth of this market. Some of the major companies dominating the service robotics market include KUKA AG (Germany), Bluefin Robotics (US), iRobot Corporation (US), Adept Technology, Inc. (US), Northrop Grumman Corporation (US), GeckoSystems Intl. Corp. (US), ECA Group (France), and Honda Motor Co., Ltd. (Japan). ...

 3/6/2018 |  Semiconductors


Wearable Medical Devices Market By Type (Activity Monitors, Smart Watches, Smart Clothing, Patches), Distribution Channel (Pharmacies, Online Channel, Hypermarkets) Device Type [Diagnostic & Monitoring Devices, Vital Signs Monitoring Devices (Heart Rate Monitors, Pulse Oximeters, Blood Pressure Monitors) - Global Market Trends & Forecasts Upto 2025

The global wearable medical devices market is estimated to reach 14.6 Billion by 2023 from $ 5.5 Billion in 2017, at a CAGR of 18.5% during the forecast period during the forecast period of 2018-2023. The market for wearable medical devices is expected to attain a considerably high growth in coming years as their impact is not merely limited to the usual customer uses, like activity tracking and smart watches but are extended deep into medical applications. A majority of successful wearable devices are the ones that are designed to aid diagnosis, monitoring, and treatment of specific medical conditions that the smartphone apps are unable to address. Unlike health apps or conventional wearables that merely track the number of calories burned by the user, medical wearables are designed to address a range of specific medical conditions like chronic obstructive pulmonary disease, asthma, heart arrhythmia, pain management, breast cancer, and various other ailments. Instead of just tracking data on smart phone, medical wearables allow the medical personnel to compile relevant data and offer diagnosis, aid patient management, and help research studies. This is one of the key drivers of this market. Additionally, the growing prevalence of diseases that requiring continuous monitoring is another major trend that is responsible for propelling the market for wearable medical device market. Some of the specific areas like patient monitoring, home healthcare, and health and fitness are key factors responsible for this trend. Furthermore, technological advancements and appealing product features like smartphone connectivity coupled with the increasing smart phone penetration and growth in the healthcare smart phone apps are also likely to drive the adoption of wearable medical devices. Moreover, there is an increasing requirement for self-health monitoring and preventive medicine owing to the projected exponential increase in the geriatric population. Recent advancements in these technologies have the capability to reduce the overall costs for prevention and monitoring. This is possible by constantly monitoring health indicators in various areas, which is easily achievable through the use of wearable medical devices. Moreover, to structure the medical Internet of Things, these wearable devices now have been efficiently integrated with telemedicine and telehealth. All these factors are collectively responsible for driving the growth of this market However, some of the major restraining factors in this market include the complexity involved in their designing and development process, their high cost and regulatory obstacles. The stringent safety and accuracy standards that these devices need to meet is a key factor responsible for the current limited adoption of these devices. Regulatory obstacles, compliance issues, and the insurance reimbursement must all be considered when anticipating the broader use of medical-grade wearable devices. Moreover, the accuracy of popular wellness trackers is highly debated and these wearable medical products need to be validation and approval from the U.S. Food and Drug Administration and ISO standards, where the accuracy and reliability is strictly monitored. Moreover, these devices present certain limitations, as most of these are not suitable for the medical monitoring of high risk patients. In-spite of these limitations, the perceived benefits successful products which are yet to be launched will drive the market to nearly $ 5.5 billion. The segments are categorized by type (activity monitors, smartwatches, smart clothing, patches), distribution channel (pharmacies, online channel, hypermarkets) by device type [diagnostic & monitoring devices, vital signs monitoring devices (heart rate monitors, pulse oximeters, blood pressure monitors, glucose monitoring devices, sleep monitoring devices, fetal monitoring & obstetric devices, neuromonitoring devices), therapeutic devices (pain management devices, rehabilitation devices, respiratory therapy devices, insulin pumps], by application (sports & fitness, remote patient monitoring, home healthcare) Some of the key answers the study intends to provide are- • Why activity monitors segment is expected to grow at a faster rate? • What are the impacts of the regulatory scenario? • Which companies having an edge? • Why sports and fitness segment is expected to grow at a higher growth rate? • What are the latest technology trends? • Survey on “Customer Preference on wearable medical devices”. Some of the major players dominating the market are Philips, Garmin, Lifewatch, Omron, Drägerwerk, Nokia Technologies, Jawbone, Polar Electro, World Global Network [Wor(L)D], Activeinsights, Vitalconnect, Xiaomi, Misfit and Monica Healthcare. ...

 3/6/2018 |  Healthcare


Food Safety Testing Market The total food safety testing market is valued at USD 12.9 billion as on 2017 and is anticipated to reach USD 20 billion by the end of 2023, growing at a CAGR of 7.5%. The main growth driving factors include stringent international standards and regulation, improvements in food safety, performance and quality, continuous food inspection, and advances in food testing technologies. Factors like increasing incidences of foodborne illness, globalization of food supply chain management, easy accessibility of advanced Rapid Technologies and increasing awareness about chemical contamination in food industrial sector are the prime drivers that fuels the growth of the Global food safety testing market. In addition, the strict government rules and norms coupled with the increasing demand of ready to eat food products are also responsible in driving the need for testing of food products that are available in the market. However, the expensive cost of food safety testing services along with the lack of food safety infrastructure in developing regions are expected to hamper the growth of this market. Moreover, the long and time consuming testing processes, and lack of standardization in sample collection serves to be the major challenges of safety testing market. The growing consumer awareness about food safety and its methods coupled with the increasing count of capital investments are anticipated to create great opportunities for food safety testing market in the developing countries. The food safety testing market is segmented on the basis of contaminants, testing technologies, end users and region. On the basis of contaminants this market is further fragmented into the pathogens, toxins, genetically modified organisms (GMO), pesticides and others. The pathogen category for the elaborated into E. Coli, Campylobacter, Listeria, Salmonella and Other. Among which, the pathogen segment is expected to have the largest Market share in 2017; due to its major role in making the food toxic and degrading the food quality. Moreover, the increasing prevalence of foodborne illness and other conditions are further expected to propel the growth of this market. On the basis of testing technologies, the food safety testing market is classified into chromatography, culture media, rapid assays, emerging technologies, biosensors or biochips and others. Chromatography is expected to dominate the market during the forecast period, accounting to the increasing research and development activities, technical advancements in food safety processes and optimization of food testing methods. However, the applications of biosensors or biochips is further expected to create awareness about food safety measures and thus it is responsible for fueling the growth of food safety testing market. On the basis of end users the food safety testing market is fragmented into meat & poultry, dairy products, processed food, seafood, beverages, fruits & vegetables, and others. Processed foods led this market during the base years, but the increasing consumption of meat and poultry products is expect to hold the largest market share during the forecast. As meat and poultry products are more susceptible to contamination. However, the adoption of Hazard Analysis Critical Control Points or HACCP in slaughterhouse and processing plants prevents the contamination of food products and assures the delivery of quality food products to the consumers. On the basis of region, the food safety testing market is segmented into North America, Europe, Asia and Row. Overall, North America dominates this market, due to the presence of major players in this region, elevating count of population, adoption and implementation of strict norms to assure quality food products are some of the prime factors fuelling the growth of this market. In addition, the supportive government against food contamination coupled with the increasing count of working women is also elevating the need for packed and convenience food in the market, which is further increasing the demand of food safety testing. The leading major players in the market are Eurofins, SGS SA, Intertek Group PLC, Bureau Veritas S.A., ALS Limited, Microbac Laboratories, Inc, Bureau Veritas SA, Neogen Corporation, SCS Global Services, Microbac Laboratories, Laboratory Corporation of America Holdings, Mérieux Nutrisciences, Asurequality Ltd., Romer, Labs Division Holding GmbH, and Genetic ID NA, Inc. ...

 3/27/2018


Bio-Stimulants Market The total food safety testing market is anticipated to reach USD 3.6 billion by the end of 2023, growing at a CAGR of 10.8% from 2018-2023. The bio-stimulant market is majorly driven by the increasing adoption of eco-friendly and organic food products in the market. Some of the other factors contributing towards the growth are growing focus on enhancement of yield and productivity per hectare and implementation of precise farming. Additionally, the strong product portfolio and enhancement of market portfolio in developing region create great opportunities for bio-stimulants. However, the availability of substitutes, expensive research and development activities, lack of awareness among farmers and time consuming process hampers the growth of bio-stimulants market. Additionally, the adoption of plant phenotyping and focus on farm profitability are the major trending issues that are responsible for increasing the adoption of bio-stimulants by the farmers. The bio-stimulants market is segmented on the basis of crop type, form, active ingredients, applications and geography. On the basis of crop type, the market is further fragmented into cereals, oil seeds, turfs & ornamentals, fruits & vegetables and others. Among which, cereals segment has the largest market share, which is due to the increased production of food grains in order to feed the elevating population, adoption of sustainable farming practices due to the availability of limited land and water and the positive effect of bio-stimulants against abiotic stress. On the basis of form, the bio-stimulant market is categorized into dry and liquid bio-stimulant. The dry formulation of bio-stimulant is recorded to have largest market share in the base year. Factors like easy handling and transportation, improvement in photosynthesis coupled with lateral but development process, delaying of aging process of plant tissues and promotion of cell division and plant respiration activity results in increased demand of dry form of bio- stimulant in the market. The active ingredient category of bio-stimulants market is fragmented into humic acid, fulvic acid, trace minerals, seaweed extracts, microbial soil amendments, vitamins, amino acids, chitin & chitosan, protein hydrolysates, and others. The seaweed extracts segment holds the largest market share and is expected to grow with the same pace during the forecast years. It may be due to the benefits of extract based ingredients in terms of aeration and advanced soil structures, elevation of seed germination processes, and growing of biotic and abiotic tension resistant yield. On the basis of application, the bio-stimulant market is categorized into foliar treatment, seed treatment, soil treatment, potassic, and others. The foliar segment holds the largest market share, owing to the efficiency of foliar sprays for instant results, enhanced productivity factor, high rate of absorption and enhanced farming technologies. Geographically, the bio-stimulant market is divided into North America, Europe, Asia and ROW. Among all, Europe, followed by Asia, is expected to dominate this market. Factors like growing awareness about susceptible farming, increasing demand of important fruit and field crops, strict rules on environmental safety, and increasing capital investments in research and development activities are responsible and boosting the growth of bio-stimulants market. The key players operating in this industry are Arysta Life science Limited, Biolchim S.P.A., Biostadt India Limited, Isagro S.P.A., Italpollina S.P.A., Lida Plant Research S.L., Monsanto Company, Novozymes A/S, Syngenta Ag, and Valagro S.P.A. ...

 3/27/2018


The healthcare BPO market is estimated to reach USD 330 billion by 2023 growing at a CAGR of 11.0 from 2018-2023. The healthcare BPO market is primarily driven by elevating cost-saving factor, growing perception for recovery audits coupled with increasing research and development activities. However, the service reliability issue along with the complications and concerns of data privacy may hamper the growth of this market. In addition, implementation of IT in Healthcare sector serve to be the growing opportunity for healthcare BPO market. The adoption of BPO services is also responsible for propelling the growth of the market. The healthcare BPO market can be segmented into payer services, provider services, and pharmaceutical services. The payer services can be further segmented into human resource management, claims management, Customer Relationship Management (CRM), operational/administrative management, product development, care management and provider management. The induced pressure to reduce elevating Healthcare expenditures, increasing demand of niche services, increasing demand of ICD-10 over ICD-9, adoption of automation and integrated sourcing strategies and demand and recovery audits are some of the prime factors responsible for propelling the growth of this market. The provider services of healthcare BPO market provider is further segmented into patient enrollment and strategic planning, medical billing, medical transcription, device monitoring and revenue cycle management. On the basis of provider service, revenue cycle management is expected to grow at a steady pace during the forecast period. The growing revenue cycle management market further counts to the decreasing reimbursements in the healthcare industry, resulting in the reduction of overall Healthcare expenditure coupled with supportive government policies fuels the growth of this segment in Healthcare BPO market. The Pharmaceutical segment of this market is further classified into manufacturing outsourcing, clinical data management, and pharmacovigilance services. Factors like increasing research and development activities, strict norms, adoption of IT in the healthcare sector, and upsurge demand in RCM plays a significant role in fueling the growth of the market. However, the lack of proper and accurate information and Communication Technology infrastructure coupled with interoperability issues and lack of domain expertise may restrict the growth of the market. Geographically, the healthcare BPO market segmented into North America, Europe, Asia, and ROW. On the basis of geography, North America dominates this market, accounting to the growing economic growth rate and increasing Healthcare expenditure throughout this region. This further resulted in increasing investments in Technologies responsible for simplifying the healthcare systems and services that further drive the growth of this market. Moreover, the adoption of BPO services in the healthcare industry, increase in medical transcription outsourcing services and adoption of cloud-based BPOs healthcare sector are for the responsible in creating great opportunities for this market. However, the increasing doubts over the quality of services, high attrition rate, and privacy concerns and data security issues may restrict the growth of the market. The key players operating in this industry are Accenture, Tata Consultancy Services, Genpact, Boehringer Ingelheim GmbH, Cognizant, Charles River Laboratories International Inc., Covance Inc., Infosys Limited, Lonza Group Ltd. and Quintiles Inc. ...

 3/27/2018


The e-clinical solutions market is estimated to account for USD X.X billion in 2017, and is projected to grow at a CAGR of X.X% to reach USD X.X billion by 2023. The market is majorly driven by the increasing count of clinical trials, rising number of government funding for such trials, growing need for improved data standardization, regulatory requirements associated with clinical research studies and increasing research and development of activities by pharmaceutical and biotechnology based companies. In addition, the adoption of global software solutions in clinical research studies, access data mounting from Healthcare industry and the presence of wide and strong range of products in the pipeline are another factors that boost the growth of this market. However, the lack of awareness about the benefits of a clinical solution coupled with the infrastructure of these solutions are the prime factors hindering the growth of the market. Additionally, the lack of skilled professionals and high implementation cost associated with the e-clinical solution software also restricts the demand for e-clinical solutions. Moreover, the factors like growing clinical Research activities in developing region coupled with the outsourcing of clinical trial processes are expected to create more opportunities for this market. But, the software reliability issues and patient privacy concerns still serves to be the major challenges of e-clinical solutions market. The e-clinical solutions market is segmented on the basis of product, type, delivery model, phase of clinical trials, end-users and region. On the basis of products, the market is fragmented into Electronic Data Capture and Clinical Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, Biostatistics and statistical programming solutions, Data conversion and standardization solutions, Electronic patient reported outcome solutions, e-clinical integration solutions, and Other e-clinical Solutions. On the basis of types, the e-clinical solutions market is categorized into standalone and integrated systems. Whereas on the basis of delivery models, this market is fragmented into on-premises e-clinical solutions and on-demand or cloud-based e-clinical solutions. The on-demand e-clinical solution segment is growing at a faster rate, accounting to the increasing applications of internet of things, real time study management, adoption of standard and ad hoc reporting, etc. On the basis of phase of clinical trials, this market is categorized into Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, and Phase IV Clinical Trials. Whereas, the end-user category comprises of pharmaceutical and bio-pharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, and hospitals. Among all, the pharmaceutical and bio-pharmaceutical companies is expected to dominate this market, owing to the increasing research and development activities for new product development, adoption of a centralized place to carry out all the trials related information and the improvement in clinical data management by the involvement of staff and data administrators. Geographically, the market is segmented into North America, Europe, Asia and ROW. North America dominate this market, accounting to the elevating count of clinical trials, increasing research and development activities for the development of new product, supportive government policies and changing lifestyles. However, the Asian region is also reported to have a steady growth rate during the forecast years, owing to the increasing research and development activities in this region. The key players operating in this industry are BioClinica, CRF Health, Datatrak International, Inc., Medidata Solution, Inc., Merge Health Incorporated, OmniComm Systems Inc., Oracle Corporation, and Parexel International Corporation. ...

 3/27/2018


The healthcare analytics market is estimated projected to grow at a CAGR of 28.0 % to reach USD billion by 2023. High adoption rates of electronic health record systems coupled with the application of big data in healthcare and increasing investment expenditures in healthcare industry is also boosting the growth of healthcare analytics market. However, the lack of skilled IT professionals coupled with the penetrating data integrity issues are the major restraints of healthcare analytics market. In addition, the implementation and applications of electronic health records, focus on value-based medicines and growing adoption of cloud-based analytics serve to be the prime opportunities for this market. The healthcare analytics market can be segmented on the basis of type, component, delivery mode, application, and end-user. On the basis of type, the healthcare analytics market can be segmented into descriptive analytics, diagnostic analytics, predictive analytics, and prescriptive analytics. The descriptive analytics segment, on the basis of types of healthcare analytics market, is reported to have the largest market share, owing to the increasing supportive and favorable healthcare policies that are launched by the government, progressive outcomes of clinical processes and the positive impact of social media on the healthcare industry. On the basis of components, the healthcare analytics market can further be segmented into services, software, and hardware. The services segment is further categorized as support services and business analytics services; whereas the software segment is further divided into standalone and integrated. Based on components of Healthcare analytics market, the services segment holds the largest market share accounting to the elevating need for business analytics services coupled with the advancements in technical healthcare analytics software. In addition, the emerging requirement of personalized and evidence-based medicine is also responsible for increasing the demand for service-based healthcare analytics software in the market. On the basis of delivery mode, this market is further categorized as on-premise healthcare analytics and on-demand /cloud healthcare analytics. On the basis of the delivery model of healthcare analytics market, the on-demand healthcare analytics segment is expected to grow at a steady pace; accounting to the higher flexibility, upsurge need for self-driven analytics, and pay-as-you-go cost factor. Moreover, the lack of increasing capital investments in the healthcare sector is also responsible for fuelling the growth of this market. On the basis of application, the market is fragmented into financial analytics, clinical analytics, operational and administrative analytics, and population health management/analytics. On the basis of applications of Healthcare Analytics market, operational and Administrative Services dominated this market in 2015, accounting to the elevated count of application including strategic Analytics, supply chain management and workforce. However, the financial applications are also expected to have an anticipated growth during the forecast, owing to the increasing adoption of Healthcare analytics in both governments as well as private healthcare departments. Lastly, on the basis of end-users, the healthcare analytics market is segmented into payers, providers, ACOS, HIES, MCOS, and TPAS, and third-party business analytics service providers. On the basis of end users, the payers segments are expected to dominate this market during the forecast years, accounting to the involvement and application of these services quality improvement, population health management, and personalized care. However, the increasing efficiency in Healthcare sector coupled with the reduction in the unnecessary and unwanted expenditure is also responsible for dominating this segment. Geographically, the market is divided into North America, Europe, Asia, and ROW. Geographically, North America dominates the Healthcare analytics market followed by Europe and Asia; accounting to the technological advancements in Healthcare services, implementation of regulatory clauses, and increasing government incentives that are focusing on the manufacturing and applications of personalized and customized medicines. However, the expensive nature of analytics software and services, increasing data integrity issues, the complexity of software and intensified competition may hamper the growth of Healthcare analytics market. The key players operating in this industry are Cognizant, Health Catalyst, IBM, Mede Analytics, Inc., MedAssets, Inc., McKesson Corporation, Optum, Oracle, Inc., SAS Inc., Truven Health Analytics, and Verisk Health. ...

 3/27/2018


The Infection Control market is estimated 25 billion by 2025 growing at a CAGR of 6.0 % from 2018-2025. Factors like increasing prevalence of hospital acquired infections, elevating count of surgical procedures, strict safety norms and regulations, and technical advancements in sterilization processes search to be the driving factors of this market. However, sterilization of advanced medical instruments and increasing concern related to safety of reprocessed instruments hamper the growth of this market. Additionally, high adoption rate of E-beam sterilization and merger of pharmaceutical and medical device manufacturer are also boosting the growth of the infection control market, globally. Moreover, the non-compliance issues by the end users with respect to the sterilization standards is the prime challenging factor for this market. The infection control market is segmented on the basis of products & services, end user and geography. On the basis of products & services, the market is further fragmented into sterilization products and services, disinfectants, medical non-woven and disinfector. Among all, the disinfection segment holds the largest market share, owing to the growing application of infection control systems in hospitals, the growing need for reduction of cross contamination in food and Pharmaceutical sectors and the high adaptability rate of skin and hand disinfectants. Additionally, the infection control market is also segmented on the basis of end-user, as hospitals, medical device companies, pharmaceutical companies, life science industry, clinical laboratories, food industry and others. Hospital segment dominates this market, accounting to the increasing prevalence of hospital acquired infections, elevating health related expenditures due to the increasing count of elderly population and chronic diseases. Moreover, the threat of infectious diseases like AIDS, Ebola and antivirus in the last 3 decades is also responsible in fueling the growth of the market. On the basis of geography, North America dominates this market, followed by Europe, Asia and ROW. The increasing demand for infection control products, growing awareness about hygiene and infection free environment coupled with increasing count of surgical processes also plays an important role in propelling the growth of infection control market in North America. In addition, the supportive government policies, changing lifestyles and growing geriatric population further increases the demand for infection control systems. Asian region is also expected to have a study growth during the forecast years, accounting to the growing economies of developing countries like India and China, increasing prevalence of nosocomial infections coupled with the improvement and expansion of healthcare infrastructure of this region. However, the growing outsourcing trend by the established key players of developed regions to the company's present in Asian regions is also responsible in boosting the growth of infection control market. The key players operating in this industry are 3M Company, Ahlstrom Corporation, Belimed AG, Cisa S.p.A, Getinge Group, Honeywell International, Inc., Johnson & Johnson Limited, Kimberly-Clark Corporation, Matachana Group, Nordion Inc., Sakura Global Holding Company Ltd., Sterigenics International, Inc., STERIS Corporation, Synergy Health plc, and TSO3 Inc. ...

 3/27/2018


Software Defined Everything (SDE) specifies the shift of technology in software defined way for accessing the storage, networks and data centers. The main function of SDE is to reduce the silos in the market. Software defined everything is segmented on the basis of type and application. The type segment is further bifurcated into SDN, SDS and SDDC. SDN offers a great amount of flexibility and more control over the programs and how the data packets and traffic travels across your network. Cloud Computing plays vital role in the development and growth of SDE and SDN (Software defined networking). Many IT companies are adopting cloud computing in the network infrastructure for the better and efficient management. SDN helps in allowing the cloud service providers to host multiple number of virtual networks without any need of common separation isolation methods. The SDE Market is expected to grow at a CAGR of 28% during the forecast period 2017–2023. The SDE market is driven by IoT and cloud computing adoption across industry verticals such as BFSI, aerospace & defense, retail, food & beverages, healthcare and automotive. The major players included in this report are Dell, HPE, VMware, Extreme Networks, Nexenta Systems, Riverbed Technology, Silver Peak, Metaswitch Networks, Pivot3, Infoblox and others. This report offers major trends, industry trends which is going to play a major role in SDE market during the forecasted year. Moreover, this report can also tailored as per the requirement by the users, and also available with deeper segmentation by regions, countries, and vendor profiling. ...

 3/27/2018


The total expanded polystyrene (EPS) market is expected to grow at a CAGR of 5.3% from 2017-2023 and reach $ 19.9 billion by 2023. Increasing population and urbanization in developing countries such as India, Thailand, Brazil, etc. have resulted in the growth of manufacturing sectors such as automotive, packaging, and building & construction. This growth in different industries coupled with the huge demand for packaging solutions in the food and beverage & medical and pharmaceutical sector to enhance product safety and freshness of packaged food and medicines during transportation largely drive the EPS market growth. In terms of types of EPS, white EPS accounted for the largest market share in 2017, followed by black and grey EPS. White EPS exhibits superior mechanical durability and water resistant properties, which make it suitable for various end-use industries. EPS finds its heavy utility in the building and construction sector. In 2017, the packaging and building & construction sectors emerged as the leading end use industries capturing market share. Major packaging applications include retail, food, and consumer goods. The rising demand for EPS in cold chain packaging solutions is expected to drive the market for EPS in the packaging sector. Its applications in the building and construction sector include insulated panel systems for walls, roofs, and floors as well as facades for both domestic and commercial buildings. Rising growth in the building and construction industry will eventually result in the growth of the EPS market. Automotive is another significant end use industry for EPS. Asia-Pacific was the most favoured market for EPS in 2017 that bagged the largest market share. The region is expected to grow at the fastest rate of 6.3% from 2017-2023 that will remain the leading market in 2023 as well. China subjugated the EPS market in Asia-Pacific due to the growing electrical and electronic and packaging application in the country. A shift of manufacturing companies to India, China, Indonesia, etc., has been observed because of the availability of low cost labour and raw materials. The demand for EPS in North America and Europe has been anticipated to grow at a moderate rate. EPS is banned in food packaging applications in several states of the U.S. as EPS waste causes tremendous trouble when it leaks into marine environments and contaminates water. However, EPS recycling techniques are now trending in Europe. Greenmax, DUE Recycling Systems, etc., are the companies that provide solutions to recycle EPS. The market is highly fragmented due to the presence of a large number of EPS manufacturers. Companies are working closely with consumers to address their need regarding EPS and with their latest R&D companies that are designing EPS products with exceptional properties. In 2014, BASF started to use an innovative flame retardant “PolyFr”. All of BASF’s Styropor, Neopor, and Styrodur polystyrene products for the European market have better flame retardant properties than HBCD (hexabromocyclododecane), which was used in the past. Some of the major players that operate in this market are BASF, SABIC, INEOS, Total SA, Nova Chemicals Corporation, Synthos S.A., Alpek S.A.B. De Cv, PJSC Sibur Holding, ACH Foam Technologies Inc., Versalis S.P.A, Nova Chemicals Corporation, Synbra Holding BV and Flint Hills Resources, LLC, & others. ...

 3/6/2018


The market for social robots has reached $ 7.9 billion in 2017, an increase of 7.0% over the previous year. Professional service robots accounted for two-third of the overall market and are expected to account for a major share of the service robotics market through 2023. The increase in market is expected to be driven by the increasing demand for logistics robots in manufacturing and non-manufacturing sectors, defense applications robots, and inspection and maintenance robots. Robots have now moved beyond the realm of traditional jobs doing repetitive functions, such as assembling of parts and welding, in the manufacturing and automotive industries. With the advancement in technologies, robots are becoming smarter and intelligent fostering the dissemination of new technologies and new innovations advancing the ability of robotics to assist and support humans perform several tasks. Service robots are slowly becoming ubiquitous, delivering newer efficiencies across several applications from assisting in personal tasks to professional services. With the growing integration of robotics with digital forces, such as cloud, artificial intelligence, and analytics, service robotics are bridging the gap between theory and practice in all areas of robotics and intelligent systems. [<>] The value chain of the service robotics ecosystem comprises several companies and research institutes to provide several activities from research and design to manufacturing and assembly of components to services. Service robotics are witnessing signs of robotic revolution with several startups entering the space backed by several venture capitalists as well large conglomerates incubating the newer technologies. Companies in the robotic value chain range from diverse applications. The focus of service robotics is shifting to the advanced robots with high level of artificial intelligence in terms of their interaction with the environment and the ability to continuously improve their decision making based on external feedback. Service robots have potential market in several new applications across several sectors, including logistics, education, defense and security, healthcare, agriculture and forestry, entertainment, space, domestic tasks, personal and elderly assistance, home security. Several companies are focusing on developing world class robots that are human friendly and add value to the people and businesses that deploy them. The market for social robotics is expected to be driven by the Shift from trend from the strictly structured environments into the unstructured environments and also shorter payback period and higher return on investment. Growing demand for drones from military and non-military applications also expected to boost the demand for drones. However, increase in aging population across the world would encourage the demand for rehabilitation of robots, growth potential across developing nations, persistent requirement of technologically advanced service robots, especially from defense and security verticals are presenting opportunities for service robotics. In addition, the advancements in self driving cars and artificial enabled social robots will have a potential market across the globe. Robots are expected to play a key role throughout the retail value chain including both front-end and back-end operations with the integration of big data and analytics and cloud computing, Pervasive Computing, and artificial intelligence. Several social robots are expected to hit the market in 2018-2019 with the advanced technologies and capabilities to help humans of different age groups from kids to elderly assistance. In January 2018, Paaila Technology (Nepal) launched waiter robot, a smart, reliable and autonomous robot to take valued customers' food order from kitchen to table. The company also plans to launch Room Service Robot in February 2018. In January 2018, Aflac Incorporated (US) unveiled a smart robotic companion, “My Special Aflac Duck” for children who have cancers. In January at CES 2018, Aeolus Robotics launched the Aeolus Robot, a multifunctional in-home robot powered by artificial intelligence (AI) and machine learning. FoldiMate, Inc. (US) is expected to ship the improved model of robotic laundry folding machine for home use by late 2019. North America has been dominating the market for service robotics and is expected to continue to account for the major market through 2023, followed by Europe. Technological advancements and new product developments have accounted for the major driving factor for North American market to hold the largest market share among all regions. Moreover, the presence of major players such as Amazon.Com, Inc. (U.S.), Bluefin Robotics (U.S.), iRobot Corporation (US), Google, Inc. (U.S.), Adept Technology, Inc. (U.S.), GeckoSystems Intl. Corp. (U.S.) and Northrop Grumman Corporation (U.S.) in the North American region also contribute significantly toward the growth of this market. Some of the major companies dominating the service robotics market include KUKA AG (Germany), Bluefin Robotics (US), iRobot Corporation (US), Adept Technology, Inc. (US), Northrop Grumman Corporation (US), GeckoSystems Intl. Corp. (US), ECA Group (France), and Honda Motor Co., Ltd. (Japan). ...

 3/6/2018


The global wearable medical devices market is estimated to reach 14.6 Billion by 2023 from $ 5.5 Billion in 2017, at a CAGR of 18.5% during the forecast period during the forecast period of 2018-2023. The market for wearable medical devices is expected to attain a considerably high growth in coming years as their impact is not merely limited to the usual customer uses, like activity tracking and smart watches but are extended deep into medical applications. A majority of successful wearable devices are the ones that are designed to aid diagnosis, monitoring, and treatment of specific medical conditions that the smartphone apps are unable to address. Unlike health apps or conventional wearables that merely track the number of calories burned by the user, medical wearables are designed to address a range of specific medical conditions like chronic obstructive pulmonary disease, asthma, heart arrhythmia, pain management, breast cancer, and various other ailments. Instead of just tracking data on smart phone, medical wearables allow the medical personnel to compile relevant data and offer diagnosis, aid patient management, and help research studies. This is one of the key drivers of this market. Additionally, the growing prevalence of diseases that requiring continuous monitoring is another major trend that is responsible for propelling the market for wearable medical device market. Some of the specific areas like patient monitoring, home healthcare, and health and fitness are key factors responsible for this trend. Furthermore, technological advancements and appealing product features like smartphone connectivity coupled with the increasing smart phone penetration and growth in the healthcare smart phone apps are also likely to drive the adoption of wearable medical devices. Moreover, there is an increasing requirement for self-health monitoring and preventive medicine owing to the projected exponential increase in the geriatric population. Recent advancements in these technologies have the capability to reduce the overall costs for prevention and monitoring. This is possible by constantly monitoring health indicators in various areas, which is easily achievable through the use of wearable medical devices. Moreover, to structure the medical Internet of Things, these wearable devices now have been efficiently integrated with telemedicine and telehealth. All these factors are collectively responsible for driving the growth of this market However, some of the major restraining factors in this market include the complexity involved in their designing and development process, their high cost and regulatory obstacles. The stringent safety and accuracy standards that these devices need to meet is a key factor responsible for the current limited adoption of these devices. Regulatory obstacles, compliance issues, and the insurance reimbursement must all be considered when anticipating the broader use of medical-grade wearable devices. Moreover, the accuracy of popular wellness trackers is highly debated and these wearable medical products need to be validation and approval from the U.S. Food and Drug Administration and ISO standards, where the accuracy and reliability is strictly monitored. Moreover, these devices present certain limitations, as most of these are not suitable for the medical monitoring of high risk patients. In-spite of these limitations, the perceived benefits successful products which are yet to be launched will drive the market to nearly $ 5.5 billion. The segments are categorized by type (activity monitors, smartwatches, smart clothing, patches), distribution channel (pharmacies, online channel, hypermarkets) by device type [diagnostic & monitoring devices, vital signs monitoring devices (heart rate monitors, pulse oximeters, blood pressure monitors, glucose monitoring devices, sleep monitoring devices, fetal monitoring & obstetric devices, neuromonitoring devices), therapeutic devices (pain management devices, rehabilitation devices, respiratory therapy devices, insulin pumps], by application (sports & fitness, remote patient monitoring, home healthcare) Some of the key answers the study intends to provide are- • Why activity monitors segment is expected to grow at a faster rate? • What are the impacts of the regulatory scenario? • Which companies having an edge? • Why sports and fitness segment is expected to grow at a higher growth rate? • What are the latest technology trends? • Survey on “Customer Preference on wearable medical devices”. Some of the major players dominating the market are Philips, Garmin, Lifewatch, Omron, Drägerwerk, Nokia Technologies, Jawbone, Polar Electro, World Global Network [Wor(L)D], Activeinsights, Vitalconnect, Xiaomi, Misfit and Monica Healthcare. ...

 3/6/2018